吸烟状态对干燥综合征诊断与表型的影响:匹配人群对照的队列研究
研究比较了疑似干燥综合征(SjD)患者中SjD与干燥症(sicca)的吸烟状态,并探索吸烟对疾病表型的免疫调节作用。结果显示,当前吸烟与SjD诊断几率降低独立相关(OR 0.37,95%CI 0.15-0.92),吸烟暴露与较低的免疫球蛋白和自身抗体水平相关,提示免疫调节效应而非真正保护。
要点
- 当前吸烟与SjD诊断几率降低独立相关(OR 0.37,95%CI 0.15-0.92)。
- 吸烟暴露与较低的IgG、RF水平及血清阳性率相关,独立于DMARD使用。
- 从不吸烟的SjD患者IgG水平更高(P=0.003),生物制剂ESSDAI活动更频繁(P=0.038)。
核心结论
- 吸烟与SjD诊断呈负相关(相比干燥症),但与人群对照无此关联。
- 吸烟暴露与较低的免疫球蛋白和自身抗体水平相关,提示免疫调节效应而非真正疾病保护。
- 研究支持吸烟可能关联一种代谢影响的、非自身免疫的干燥症表型。
研究设计与样本
- 研究基于OASIS队列,纳入2014年至2023年因疑似SjD转诊的成人,分为SjD或干燥症。
- 共纳入317例SjD患者和170例干燥症对照,其中257例SjD符合2016年分类标准用于主要分析。
- 吸烟状态、暴露(包-年)和被动吸烟史通过标准化问卷记录,并与2018年英国年度人口调查的匹配对照比较。
主要发现
- SjD患者中从不吸烟者比例高于干燥症(70.5% vs 53.1%,P=0.002)。
- 多变量分析中,当前吸烟与SjD诊断几率降低独立相关(OR 0.37,95%CI 0.15-0.92)。
- 从不吸烟者IgG水平更高(P=0.003),生物制剂ESSDAI活动更频繁(P=0.038)。
- 吸烟暴露与较低的IgG、RF水平和血清阳性率相关,独立于DMARD使用。
- 与人群对照相比,干燥症(而非SjD)的曾吸烟率更高(49.6% vs 39.1%,P=0.049)。
关键数值与推荐
- SjD诊断依据2016年分类标准。
- 当前吸烟与SjD诊断的OR为0.37(95%CI 0.15-0.92)。
- 从不吸烟者IgG水平差异P=0.003,生物制剂ESSDAI活动差异P=0.038。
- 干燥症与人群对照曾吸烟率比较P=0.049。
临床怎么用
- 临床评估疑似SjD时,应记录吸烟状态,当前吸烟者诊断SjD的几率较低。
- 吸烟暴露与较低的免疫球蛋白和自身抗体水平相关,解读血清学结果时需考虑吸烟状态。
- 吸烟相关的干燥症可能呈现非自身免疫表型,需注意鉴别诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To examine associations between smoking and Sjögren's disease (SjD) diagnosis, compared with non-Sjögren's sicca syndrome (sicca) and population controls, and to explore immunomodulatory effects of smoking on disease phenotype. METHODS: Adults referred for suspected SjD to the Optimising Assessment in Sjögren's Syndrome (OASIS) cohort from 2014 until 2023 were classified as SjD or sicca. Smoking status, exposure (pack-years) and passive smoking history were recorded through standardized questionnaires. Associations with diagnosis, clinical and serological parameters, and patient-reported outcomes were analysed using multivariate logistic and linear regression. Smoking patterns were further compared with matched controls from the 2018 UK Annual Population Survey. RESULTS: A total of 317 SjD patients and 170 sicca controls were included. Of these, 257 SjD met 2016 classification criteria, and were used for primary analyses. Smoking data were available for 85.0% of the cohort. SjD patients were more frequently never smokers than sicca (70.5% vs 53.1%, P = 0.002). In the multivariate analysis, current smoking (odds ratio 0.37, 95% CI 0.15-0.92) was independently associated with lower odds of SjD. Never smokers exhibited higher IgG levels (P = 0.003) and more frequent biological EULAR Sjögren's Disease Activity Index activity (P = 0.038). Smoking exposure correlated with reduced IgG, RF levels and seropositivity, independent of DMARD use. Compared with population controls, sicca, but not SjD, showed higher ever-smoking rates (49.6% vs 39.1%, P = 0.049). CONCLUSION: Smoking was negatively associated with SjD diagnosis compared with sicca, but not population controls. Smoking exposure was linked to lower immunoglobulin and autoantibody levels, suggesting an immunomodulatory effect rather than true disease protection. Findings support a potential metabolically influenced, non-autoimmune, sicca phenotype linked to smoking.
引用
- Bandeira M, Baranskaya A, Pucino V, et al. Impact of smoking status on Sjögren's disease diagnosis and phenotype: results from a cohort study with matched population controls. Rheumatology (Oxford). 2026. PMID: 42340680. doi:10.1093/rheumatology/keag334
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。